THE SYNTHESIS AND PRECLINICAL STUDIES OF NEW TREATMENTS FOR NEURODEGENERATIVE DISEASE, DIABETES MELLITUS, CONGESTIVE HEART FAILURE, ONCOLOGIC AND IMMUNOLOGIC DISEASES

神经退行性疾病、糖尿病、充血性心力衰竭、肿瘤和免疫疾病新疗法的综合和临床前研究

• 批准号: 8930676
• 负责人: CAROL E GREEN
• 金额: $ 7万
• 依托单位: SRI INTERNATIONAL
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-07-17 至 2015-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8930676
• 关键词: Archives; Congestive Heart Failure; Consultations; Contracts; Development; Diabetes Mellitus; Future; Immune System Diseases; Literature; Neurodegenerative Disorders; Preparation; Progress Reports; Research; Research Personnel; Services; Teleconferences; Writing; base; cost; meetings; pre-clinical; preclinical study

This is a general contract to support interactions between NIA staff and those of SRI in relation to: 1. Participation in regular teleconferences with the Contracting Officer’s Technical Representative (COTR) as well as internal SRI project meetings to discuss overall contract implementation and progress; 2. Preparation and submission of Monthly Technical Progress Reports and Annual Progress Reports as required by the base contract; 3. Provision of nonclinical/preclinical development consultation services to the COTR and NIA Submitting Investigators on future and to-be-assigned studies, including literature research to determine specific study requirements and scope. These activities usually include iterative discussions and provision of written preliminary study outlines to the COTR and Submitting Investigator to define specific study needs; and 4. Retention costs of archived GLP-regulated studies.

这是一项一般合同，旨在支持NIA工作人员与SRI工作人员之间在以下方面的互动： 1.参加与承包人技术代表的定期电话会议以及SRI内部项目会议，讨论合同的整体执行和进展情况； 2.根据基础合同的要求编制和提交月度技术进度报告和年度进度报告； 3.向COTR和NIA提供非临床/临床前发展咨询服务，向他们提交关于未来和将要分配的研究的调查人员，包括确定具体研究要求和范围的文献研究。这些活动通常包括反复讨论和向COTR提供书面初步研究大纲，并提交调查员以确定具体的研究需要；以及 4.由GLP管理的存档研究的保留成本。